Armistice Capital, LLC 13D and 13G filings for Moleculin Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 1,586,521 4.990% | 336,521 (+26.92%) | Filing |
| 2025-05-15 3:30 pm Purchase | 2025-03-31 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 1,250,000 8.930% | 910,233 (+267.90%) | Filing |
| 2025-02-14 5:51 pm Purchase | 2024-12-31 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 339,767 9.990% | 38,779 (+12.88%) | Filing |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 300,988 9.990% | 300,988 (New Position) | Filing |